Literature DB >> 29239009

Falls in older adults with multiple myeloma.

Tanya M Wildes1, Mark A Fiala1.   

Abstract

OBJECTIVE: To examine the prevalence of falls, factors associated with falls and the relationship between falls and survival in older adults with multiple myeloma.
METHODS: In an analysis of the Surveillance, Epidemiology and End Results (SEER)-Medicare Health Outcomes Survey (MHOS)-linked database, we examined 405 older adults with multiple myeloma (MM) and 513 matched non-cancer controls. The primary outcome was self-reported within the past 12 months. Age, race, gender, symptoms, and comorbidities were self-reported in the MHOS. Survival was calculated from SEER data.
RESULTS: Of the patients with MM, 171 were within 1 year of diagnosis (cohort 1) and 234 were ≥1 year postdiagnosis (cohort 2). Patients in cohorts 1 and 2 were more likely to have fallen than controls (26% and 33% vs 23%, P = .012). On multivariate analysis, among patients with myeloma (combined cohorts 1 and 2), factors associated with falls included self-report of fatigue (aOR 2.52 [95% CI 1.34-4.93]), depression (aOR 1.90 [95% CI 1.14-3.18]), or poorer general health (aOR 1.86 [95% CI 1.05-3.36]). Falls were not associated with survival.
CONCLUSIONS: Older adults with MM have a greater prevalence of falls than matched controls. Self-reported fatigue, depression, and poorer general health are associated with greater odds of falls.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cancer; elderly; falls; geriatric assessment; multiple myeloma

Mesh:

Year:  2018        PMID: 29239009      PMCID: PMC5814335          DOI: 10.1111/ejh.13009

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  37 in total

1.  Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study.

Authors:  Arti Hurria; Kayo Togawa; Supriya G Mohile; Cynthia Owusu; Heidi D Klepin; Cary P Gross; Stuart M Lichtman; Ajeet Gajra; Smita Bhatia; Vani Katheria; Shira Klapper; Kurt Hansen; Rupal Ramani; Mark Lachs; F Lennie Wong; William P Tew
Journal:  J Clin Oncol       Date:  2011-08-01       Impact factor: 44.544

2.  Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-dose therapy.

Authors:  María-Victoria Mateos; Sara Bringhen; Paul G Richardson; Juan Jose Lahuerta; Alessandra Larocca; Albert Oriol; Mario Boccadoro; Ramón García-Sanz; Francesco Di Raimondo; Dixie-Lee Esseltine; Helgi van de Velde; Avinash Desai; Anil Londhe; Jesús F San Miguel; Antonio Palumbo
Journal:  Haematologica       Date:  2014-04-24       Impact factor: 9.941

3.  Risk factors for falls among elderly persons living in the community.

Authors:  M E Tinetti; M Speechley; S F Ginter
Journal:  N Engl J Med       Date:  1988-12-29       Impact factor: 91.245

4.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

Review 5.  Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues.

Authors:  Michel Delforge; Joan Bladé; Meletios A Dimopoulos; Thierry Facon; Martin Kropff; Heinz Ludwig; Antonio Palumbo; Philip Van Damme; Jesús F San-Miguel; Pieter Sonneveld
Journal:  Lancet Oncol       Date:  2010-11       Impact factor: 41.316

6.  Prevalence of self-reported falls, balance or walking problems in older cancer survivors from Surveillance, Epidemiology and End Results-Medicare Health Outcomes Survey.

Authors:  Min H Huang; Jennifer Blackwood; Monica Godoshian; Lucinda Pfalzer
Journal:  J Geriatr Oncol       Date:  2017-06-08       Impact factor: 3.599

7.  Association of cancer with geriatric syndromes in older Medicare beneficiaries.

Authors:  Supriya G Mohile; Lin Fan; Erin Reeve; Pascal Jean-Pierre; Karen Mustian; Luke Peppone; Michelle Janelsins; Gary Morrow; William Hall; William Dale
Journal:  J Clin Oncol       Date:  2011-03-14       Impact factor: 44.544

8.  Falls and physical performance deficits in older patients with prostate cancer undergoing androgen deprivation therapy.

Authors:  Kathryn Bylow; William Dale; Karen Mustian; Walter M Stadler; Miriam Rodin; William Hall; Mark Lachs; Supriya G Mohile
Journal:  Urology       Date:  2008-06-17       Impact factor: 2.649

9.  The fall rate of older community-dwelling cancer patients.

Authors:  Martine T E Puts; Johanne Monette; Veronique Girre; Christina Wolfson; Michèle Monette; Gerald Batist; Howard Bergman
Journal:  Support Care Cancer       Date:  2012-09-01       Impact factor: 3.603

10.  Fall predictors in older cancer patients: a multicenter prospective study.

Authors:  Nathalie Vande Walle; Cindy Kenis; Pieter Heeren; Katrien Van Puyvelde; Lore Decoster; Ingo Beyer; Godelieve Conings; Johan Flamaing; Jean-Pierre Lobelle; Hans Wildiers; Koen Milisen
Journal:  BMC Geriatr       Date:  2014-12-15       Impact factor: 3.921

View more
  5 in total

Review 1.  Approach to the treatment of the older, unfit patient with myeloma from diagnosis to relapse: perspectives of a US hematologist and a geriatric hematologist.

Authors:  Tanya M Wildes; Kenneth C Anderson
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Geriatric Assessment in Older Adults with Multiple Myeloma.

Authors:  Tanya M Wildes; Sascha A Tuchman; Heidi D Klepin; Joseph Mikhael; Kathryn Trinkaus; Keith Stockerl-Goldstein; Ravi Vij; Graham Colditz
Journal:  J Am Geriatr Soc       Date:  2018-12-13       Impact factor: 5.562

3.  Bortezomib in first-line therapy is associated with falls in older adults with multiple myeloma.

Authors:  Kelly L Schoenbeck; Mark A Fiala; Tanya M Wildes
Journal:  J Geriatr Oncol       Date:  2021-03-07       Impact factor: 3.929

4.  Falls in older adults with cancer: an updated systematic review of prevalence, injurious falls, and impact on cancer treatment.

Authors:  T M Wildes; S Alibhai; S Sattar; K Haase; S Kuster; M Puts; S Spoelstra; C Bradley
Journal:  Support Care Cancer       Date:  2020-07-16       Impact factor: 3.603

Review 5.  Barriers and facilitators related to undertaking physical activities among men with prostate cancer: a scoping review.

Authors:  S Sattar; K R Haase; C Bradley; E Papadopoulos; S Kuster; D Santa Mina; M Tippe; A Kaur; D Campbell; A M Joshua; C Rediger; O Souied; S Alibhai
Journal:  Prostate Cancer Prostatic Dis       Date:  2021-06-09       Impact factor: 5.455

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.